NDC 51655-413

Lisinopril and HCTZ

Lisinopril And Hydrochlorothiazide

Lisinopril and HCTZ is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Northwind Pharmaceuticals, Llc. The primary component is Hydrochlorothiazide; Lisinopril.

Product ID51655-413_0dfdb771-023a-4426-bfc7-49a5e896232f
NDC51655-413
Product TypeHuman Prescription Drug
Proprietary NameLisinopril and HCTZ
Generic NameLisinopril And Hydrochlorothiazide
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2014-07-10
Marketing CategoryANDA / ANDA
Application NumberANDA077912
Labeler NameNorthwind Pharmaceuticals, LLC
Substance NameHYDROCHLOROTHIAZIDE; LISINOPRIL
Active Ingredient Strength25 mg/1; mg/1
Pharm ClassesIncreased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 51655-413-30

30 TABLET in 1 BOTTLE, DISPENSING (51655-413-30)
Marketing Start Date2014-07-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51655-413-30 [51655041330]

Lisinopril and HCTZ TABLET
Marketing CategoryANDA
Application NumberANDA077912
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-07-10
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
HYDROCHLOROTHIAZIDE25 mg/1

OpenFDA Data

SPL SET ID:3984e6b9-2d88-47f0-af09-cce428bba14f
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197887

    • Pharmacological Class

    • Increased Diuresis [PE]
    • Thiazide Diuretic [EPC]
    • Thiazides [CS]
    • Angiotensin Converting Enzyme Inhibitor [EPC]
    • Angiotensin-converting Enzyme Inhibitors [MoA]

    NDC Crossover Matching brand name "Lisinopril and HCTZ" or generic name "Lisinopril And Hydrochlorothiazide"

    NDCBrand NameGeneric Name
    51655-413Lisinopril and HCTZLisinopril and HCTZ
    0185-0152Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0185-0173Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0185-7100Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0378-1012Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide
    0378-2012Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide
    0378-2025Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide
    0591-0860Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0591-0861Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0591-0862Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0615-7577Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0615-7581Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0615-7582Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    10544-236Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    10544-237Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    10544-564LISINOPRIL AND HYDROCHLOROTHIAZIDELISINOPRIL AND HYDROCHLOROTHIAZIDE
    16571-791Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    16571-792Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0143-1262Lisinopril with HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0143-1263Lisinopril with HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0143-1264Lisinopril with HydrochlorothiazideLisinopril and Hydrochlorothiazide
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.